期刊文献+
共找到19篇文章
< 1 >
每页显示 20 50 100
心血管紧缩素I—转换酶抑制型缩氨酸的抑制性的稳定性
1
《中外食品加工技术》 2003年第1期87-87,共1页
关键词 血管紧缩素I-转换酶 抑制型缩氨酸 稳定性 活性 大豆蛋白
下载PDF
The inhibitory effects of sevoflurane on angiotensin Ⅱ-induced, p44/42 mitogen-activated protein kinase-mediated contraction of rat aortic smooth muscle 被引量:1
2
作者 于金贵 《中国麻醉与镇痛》 2005年第2期117-117,共1页
关键词 抑制作用 血管紧缩素 p44/42分裂 蛋白激酶 动脉平滑肌
下载PDF
递增负荷运动中醛固酮、可的松及其相关因子的变化研究
3
作者 许玲 《中国体育科技》 北大核心 2005年第3期20-22,58,共4页
8名高水平女子短跨运动员在功率自行车上进行最大耗氧量(从0 %~10 0 % VO2 max负荷)的测试。在测试中每隔5 0W的负荷量测量醛固酮(Ald)、可的松(Cor)、血管紧缩素II(AngII)、促肾上腺皮质激素(ACTH)、血浆钾(K+ )浓度。结果显示,Ald、... 8名高水平女子短跨运动员在功率自行车上进行最大耗氧量(从0 %~10 0 % VO2 max负荷)的测试。在测试中每隔5 0W的负荷量测量醛固酮(Ald)、可的松(Cor)、血管紧缩素II(AngII)、促肾上腺皮质激素(ACTH)、血浆钾(K+ )浓度。结果显示,Ald、AngII、ACTH出现了明显的增长(P <0 .0 1) ,Ald从安静时的15 6 .8±12 .1pmol/L上升到力竭时的334.6±15 .4pmol/L ,AngII从安静时的9.3±0 .9pmol/L上升到4 7.2±1.9pmol/L ,ACTH从2 .5±0 .5pmol/L上升到10 .7±0 .9pmol/L。而Cor从静止时的184 .5±14 .6nmol/L上升到力竭时的2 13.7±16 .2nmol/L(P <0 .0 5 ) ;当运动强度≥6 0 % VO2 max时,Ald开始明显地增多,而Cor只是在力竭(10 0 % VO2 max)时才发生较明显的增长。表明:在人体运动过程中,醛固酮的增多是先于可的松的。在递增负荷运动过程中,醛固酮与运动强度(r =0 .79)、血浆钾(r =0 .79)、ACTH(r =0 .5 9)、血管紧缩素II(r=0 .5 6 )有着明显的相关性。这一发现揭示了醛固酮在递增负荷运动过程中受可的松、血管紧缩素II、ACTH分泌、血浆K+ 等因素的影响,其中,醛固酮的增长与运动强度和血浆K+ 关系最为密切。 展开更多
关键词 跨栏 女子 优秀运动员 递增负荷运动 醛固酮 可的松 血管紧缩素 促肾上腺皮质激 血浆钾
下载PDF
Sevoflurane inhibits angiotensin Ⅱ-induced, protein kinase C-mediated, not Ca^2+ -elicited, contraction of rat aortic smooth muscle
4
作者 于金贵 《中国麻醉与镇痛》 2005年第2期114-114,共1页
关键词 血管紧缩素 抑制作用 蛋白激酶C 动脉平滑肌 钙离子通道
下载PDF
Optimization of angiotensin I-converting enzyme (ACE) inhibition by rice dregs hydrolysates using response surface methodology 被引量:9
5
作者 何国庆 玄国东 +2 位作者 阮晖 陈启和 徐莹 《Journal of Zhejiang University-Science B(Biomedicine & Biotechnology)》 SCIE EI CAS CSCD 2005年第6期508-513,共6页
Angiotensin I-converting enzyme (ACE) inhibitory peptides have been shown to have antihypertensive effects and have been utilized for physiologically functional foods and pharmaceuticals. The ACE inhibitory ability of... Angiotensin I-converting enzyme (ACE) inhibitory peptides have been shown to have antihypertensive effects and have been utilized for physiologically functional foods and pharmaceuticals. The ACE inhibitory ability of a hydrolysate is de- termined by its peptide composition. However, the peptide composition of a hydrolysate depends on proteolytic enzyme and the hydrolysis conditions. In this study, the effect of process conditions on the ACE inhibitory activity of rice dregs hydrolyzed with a trypsin was investigated systematically using response surface methodology. It was shown that the ACE inhibitory activity of rice dregs hydrolysates could be controlled by regulation of five process conditions. Hydrolysis conditions for optimal ACE inhibition were defined using the response surface model of fractional factorial design (FFD), steepest ascent design, and central composite design (CCD). 展开更多
关键词 血管紧缩素 缩氨酸 酶抑制剂 抗高血压药物
下载PDF
ACEI attenuates the progression of CCl_4-induced rat hepatic fibrogenesis by inhibiting TGF-β1, PDGF-BB, NF-κB and MMP-2,9 被引量:12
6
作者 Xu Li Ying Meng +2 位作者 Xi-Shan Yang Ling-Fei Mi Shao-Xi Cai 《World Journal of Gastroenterology》 SCIE CAS CSCD 2005年第31期4807-4811,共5页
AIM: Angiotensin Ⅱ has pro-fibrotic function in the liver.Blockade of the renin-angiotensin-aldosterone-system (RAAS) attenuates hepatic fibrosis. The aim of the present study was to determine the mechanism of angiot... AIM: Angiotensin Ⅱ has pro-fibrotic function in the liver.Blockade of the renin-angiotensin-aldosterone-system (RAAS) attenuates hepatic fibrosis. The aim of the present study was to determine the mechanism of angiotensinconverting enzyme inhibitor (ACEI) on the progression of rat hepatic fibrosis.METHODS: Forty male Wistar rats were divided into three groups. Model group (Mo): The rats were injected subcutaneously with 40% of CCl4 0.25 mL/100 g. Perindopril group (Pe): The rats were injected subcutaneously with administrated. Control group (Nc): the rats were treated with olive oil only. After 4 and 6 wk, the rats were killed.The liver sections were stained with Masson. The protein expressions of AT1R, TGF-β1 and PDGF-BB were examined by Western blot. Nuclear factor κB (NF-κB) DNA binding activity was examined by EMSA (Electrophoretic gel mobility shift assay). Matrix metalloproteinase-2,9(MMP-2,9) activity was assessed by zymography. Serum laminin (LN) and hyaluronic acid (HA) were measured using radioimmunoassays.RESULTS: Using Western blot, we clearly provided direct evidence for the expression of AT1R in liver. The expression was up-regulated when fibrogenesis occurred. Perindopril treatment significantly reduced mean fibrosis score,protein levels of AT1R, TGF-β1 and PDGF-BB, serum levels of HA and LN, and the activity of MMP-2,9. NF-κB DNA binding activity markedly increased in model group, perindopril treatment considerably reduced NF-κB DNA binding activity.CONCLUSION: Perindopril attenuates CCl4-induced hepatic fibrogenesis of rat by inhibiting TGF-β1, PDGF-BB,NF-κB and MMP-2,9. 展开更多
关键词 血管紧缩素转化酶抑制剂 四氯化碳 肝纤维化 TGF-Β1 核因子-κB
下载PDF
A simple and efficient synthesis of the valsartan 被引量:5
7
作者 Chen Xi Zhang Guo Jun Zheng Fu Qiang Bi Yu Lin Li 《Chinese Chemical Letters》 SCIE CAS CSCD 2008年第7期759-761,共3页
Valsartan 1,最重要的代理人之一在今天的 antihypertensive 治疗使用了,被综合从 2 在 60% 的全面收益通过四走的 l-valin 甲基酉旨 hydrochloride 开始。关键步骤包含联合的催化钯的铃木。这个方法与以前报导的综合体联系的缺点克... Valsartan 1,最重要的代理人之一在今天的 antihypertensive 治疗使用了,被综合从 2 在 60% 的全面收益通过四走的 l-valin 甲基酉旨 hydrochloride 开始。关键步骤包含联合的催化钯的铃木。这个方法与以前报导的综合体联系的缺点克服许多并且对工业生产更合适。 展开更多
关键词 抗高血压药物 药物合成 Suzuki联接 血管紧缩素
下载PDF
Effects of angiotensin II on connexin 43 of VSMCs in arteriosclerosis 被引量:3
8
作者 CAI Wei RUAN Li-ming WANG Yi-na CHEN Jun-zhu 《Journal of Zhejiang University-Science B(Biomedicine & Biotechnology)》 SCIE CAS CSCD 2006年第8期648-653,共6页
Objective: To observe the effect of angiotensin II (Ang II) on expression of gap junction channel protein connexin 43 (Cx43) in the proliferation process of vascular smooth muscle cells (VSMCs) during the early stage ... Objective: To observe the effect of angiotensin II (Ang II) on expression of gap junction channel protein connexin 43 (Cx43) in the proliferation process of vascular smooth muscle cells (VSMCs) during the early stage of arteriosclerosis. Methods: Thirty-two adult male rabbits were randomly divided into 4 groups. Rabbits in Group A were fed common diet while others in Groups B, C, and D were fed high-cholesterol diet. Losartan (10 mg/(kg?d)) and ramipril (0.5 mg/(kg?d)) were added in the diet of Groups C and D, respectively. The animals were sacrificed after 8 weeks and abdominal aortas were removed and dissected. The expression of Cx43 was assayed using RT-PCR and Western Blotting analysis. Results: Cx43 was increased markedly in both protein and mRNA level in Groups B, C, and D fed high-cholesterol diet compared with that in control group (P<0.01). Cx43 level in losartan or ramipril treated groups was higher than that in control group (P<0.01, P<0.05), but lower than that in high-cholesterol diet groups (P<0.05, P<0.01). Conclusion: Cx43 level was upregulated in VSMCs during early atherosclerosis. Losartan and ramipril can inhibit the expression of Cx43. 展开更多
关键词 动脉硬化症 连接蛋白 MRNA VSMCS 血管紧缩素
下载PDF
Clinical Observation of Irbesartan in Treatment of Vasovagal Syncope
9
作者 YangHan Xue-yingLü Wei-liJiang Yun-meiYang Tian-zhiChen 《Chinese Medical Sciences Journal》 CAS CSCD 2005年第1期15-15, ,共1页
关键词 临床观察 血管迷走神经昏厥 茶碱 东莨菪碱 血管紧缩素
下载PDF
INHIBITORY EFFECT OF ANGIOTENSIN II TYPE 1 RECEPTOR-ASSOCIATED PROTEIN ON VASCULAR SMOOTH MUSCLE CELL GROWTH AND NEOINTIMAL FORMATION
10
作者 Zhen Li Zhong-gao Wang +1 位作者 Xiu Chen Xiao-dong Chen 《Chinese Medical Sciences Journal》 CAS CSCD 2007年第1期22-26,共5页
Objective To investigate the mechanism of a novel angiotensin Ⅱ type 1 receptor-associated protein (ATRAP) interfering with angiotensin II type 1 (AT1) receptor-mediated vascular smooth muscle cell (VSMC) growth and ... Objective To investigate the mechanism of a novel angiotensin Ⅱ type 1 receptor-associated protein (ATRAP) interfering with angiotensin II type 1 (AT1) receptor-mediated vascular smooth muscle cell (VSMC) growth and neointimal formation. Methods VSMCs isolated from thoracic aorta of adult Sprague-Dawley (SD) rats were used in this study. ATRAP cDNA was subcloned into pcDNA3 vector and then transfected into VSMCs. DNA synthesis and extracellular signal-regulated kinase (ERK) and phospho-ERK expressions in VSMCs were assayed by measurement of 3H thymidine incorporation and Western blotting, respectively. Morphological changes were observed in the balloon injured artery with or without transfection of ATRAP cDNA using 12-week-old male SD rats. Results ATRAP overexpression in VSMCs inhibited angiotensin II(Ang II)-induced 3H thymidine incorporation 48 hours after Ang II stimulation (P<0.05). In VSMC, Ang II stimulation increased the phosphorylation of ERK, which reached the peak around 60 minutes. The activation of phospho-ERK was significantly decreased by ATRAP (P<0.05). Neointimal formation was markedly inhibited by ATRAP overexpression in injuried arteries. Conclusions The AT1 receptor-derived activation of ERK plays an essential role in Ang II-induced VSMC growth. The growth inhibitory effects of ATRAP might be due to interfering with AT1 receptor-mediated activation of ERK in VSMC growth and neointimal formation. 展开更多
关键词 抑制作用 血管紧缩素 蛋白质 血管平滑肌细胞 胸腔动脉
下载PDF
New process for preparing benazepril precursor
11
作者 Kafssi Hassan 王涛 +1 位作者 王芳 万平玉 《化工学报》 EI CAS CSCD 北大核心 2007年第10期2558-2560,共3页
The present work relates to a new synthesis process for the preparation of 3-[(1-ethoxycarbonyl-3-phenylpropyl)-amino]-2,3,4,5-tetrahydro-2-oxo-1H-1-benzazepine-1-acetate tert butyl ester(EPTAB),the precursor of benaz... The present work relates to a new synthesis process for the preparation of 3-[(1-ethoxycarbonyl-3-phenylpropyl)-amino]-2,3,4,5-tetrahydro-2-oxo-1H-1-benzazepine-1-acetate tert butyl ester(EPTAB),the precursor of benazepril HCl.The reaction conditions were optimized.The diastereomeric products were separated by flash column chromatography.The structures of the products were characterized with IR and NMR. 展开更多
关键词 制备 前体 血管紧缩素转换酶 盐酸贝那普利
下载PDF
Protherics公司开始对高血压疫苗进行Ⅱ期临床试验
12
《中国医药生物技术》 CSCD 2009年第4期320-320,共1页
位于英国的生物制药上市公司Protherics PLC的血管紧缩素治疗性疫苗(angiotensin therapeutic vaccine,ATV)已经进入Ⅱ期l临床试验阶段。该药物是用于对高血压的治疗。据该公司负责人称,目前大概有70%的高血压患者并没有适当地控... 位于英国的生物制药上市公司Protherics PLC的血管紧缩素治疗性疫苗(angiotensin therapeutic vaccine,ATV)已经进入Ⅱ期l临床试验阶段。该药物是用于对高血压的治疗。据该公司负责人称,目前大概有70%的高血压患者并没有适当地控制自己的血压。采用疫苗注射的方法应该能使患者更加配合治疗。 展开更多
关键词 Ⅱ期临床试验 高血压患者 治疗性疫苗 血管紧缩素 上市公司 生物制药 配合治疗 疫苗注射
下载PDF
Current and Future Therapeutic Agents in the Man-agement of Heart Failure
13
作者 Jacob James Ogu 戴德哉 《Journal of Nanjing Medical University》 2003年第1期40-52,共13页
Congestive heart failare is a disease in which initially compensutory changes in car-diac, vascular, and renal functions become detrimental over time. The changes are mediated by a largenamber of neurohormones and cyt... Congestive heart failare is a disease in which initially compensutory changes in car-diac, vascular, and renal functions become detrimental over time. The changes are mediated by a largenamber of neurohormones and cytokines. Counter-regalutory hormones also play a role, but ave general-ly insuffwient to offset the adverse effects of the neurohormones or progression of the disease. Symp-toms of heart failure occurs in the presence of systolic dysfunction, usually documented by a decrease inejection fraction, or can present with impaired diastolic function occasionally labeled as heart failureuith preserved systolic function of the left ventricle. Heart failure and its treatment represent a medicalproblem of significant importance because of the high mortality associated with it despite the current ther-apy, which has substantial evidence of reduction in mortality and morbidity. Prevention or slowing of theprogressive deterioration in function of the heart and other organs involved through utilizing new agentsthat affect more or differentneurohormonal pathways may be beneficial and forms the focus of heartfailure research and drug development. However, the multiplicity of hormonal effects mandate the useof complex therapy in the management of congestive heart failure( CHF ). The new agents in addition tothe conventional therapy used in the management of heart failure are; Human B-type natriuretic peptide(in the treatment of decompensated CHF), endothelin receptor antagonists, calcium sensitizers, neutralendopeptidase ( NEP ) and vasopeptidase inhibitors, vasopressin antagonists and cytokine inhibitors. 展开更多
关键词 血管紧缩素 治疗药物 药物开发 心力衰竭
下载PDF
The Comparison Study of Renin and Angiotensin AⅡ Levels on Normal Tension Glaucoma Patients and Normal Individuals
14
作者 Hongmin Yun Pei Fu +1 位作者 Kexi Ding Qi Yang 《Eye Science》 CAS 2005年第3期192-195,共4页
Purpose: To investigate the levels of renin-angiotension system (RAS) components in normal tension glaucoma patients and normal controls. Methods: Blood samples were obtained from 11 normal tension glaucoma(NTG)patien... Purpose: To investigate the levels of renin-angiotension system (RAS) components in normal tension glaucoma patients and normal controls. Methods: Blood samples were obtained from 11 normal tension glaucoma(NTG)patients and 11 age and sex matched controls. The levels of renin and angiotensin AⅡof 11 NTG patients and normal controls were examined by radio-immunity test. Statistical analyses were performed by paired t test. Results:The levels of renin of NTG patients and normal controls are (769.085±183.217) pg/ml/n and (822.035 ±124.140) pg/ml/n, while the levels of angiotensin A Ⅱof NTG patients and normal controls are (37.347±10.669)pg/ml and (24.836±10.665)pg/ml respectively. No statistically significant differences were observed between the levels of renin and angiotensin among NTG patients and normal controls. Conclusion: There were not many abnormalities of the levels of circulating rennin and angiotensin AⅡof NTG patients in our study. Eye Science 2005 ;21 :192-195. 展开更多
关键词 高血压蛋白原酶 血管紧缩素AⅡ 青光眼 个体机制 变态反应
下载PDF
一种小肽可抑制癌细胞生长
15
《中国当代医药》 2009年第18期105-105,共1页
本刊讯 美国韦克福雷斯特大学8月26日发布消息说,该校医学院的研究人员日前通过动物实验发现,一种名为血管紧缩素(1—7)的小肽可以通过抑制血管形成的方式阻止癌细胞生长。
关键词 抑制癌细胞生长 小肽 抑制血管形成 血管紧缩素 动物实验 研究人员 医学院
下载PDF
Role of angiotensin Ⅱ receptore in proliferation of fibroblast derived from human hypertrophic
16
作者 刘宏伟 《China Medical Abstracts》 2007年第2期150-150,共1页
关键词 成纤维细胞 血管紧缩素 细胞增生 细胞学
下载PDF
武田公司正在研制糖尿病性高血压复方药
17
作者 贾永蕊(摘) 《国外药讯》 2007年第2期12-13,共2页
武田公司已经在美国开始了一种固定剂量复方的Ⅲ期临床试验,该复方由已上市的口服抗糖尿病药物Actos(pioglitazone,吡格列酮)(Ⅰ)与正在研发中的血管紧缩素Ⅱ拮抗剂TAK-536(Ⅱ)组成。公司说,他们期望该复方能够增强(Ⅰ)的药... 武田公司已经在美国开始了一种固定剂量复方的Ⅲ期临床试验,该复方由已上市的口服抗糖尿病药物Actos(pioglitazone,吡格列酮)(Ⅰ)与正在研发中的血管紧缩素Ⅱ拮抗剂TAK-536(Ⅱ)组成。公司说,他们期望该复方能够增强(Ⅰ)的药效,(Ⅰ)可以改善胰岛素的耐受性,同时还具有抗高血压和保护糖尿病人的器官免受损害的作用。据美国糖尿病协会称,美国60%的糖尿病患者同时患有高血压。目前,正在美国和欧洲进行(Ⅱ)作为单独治疗药用于高血压的Ⅱ期临床试验,而武田公司已在美国和其他60多个国家独立销售(Ⅰ)。 展开更多
关键词 糖尿病性高血压 复方药 美国糖尿病协会 GLITAZONE 口服抗糖尿病药物 研制 Ⅲ期临床试验 血管紧缩素
下载PDF
高血压病人中风的预防和治疗 被引量:1
18
作者 牛建一 田宝国 陈红兵 《中华神经医学杂志》 CAS CSCD 2007年第2期202-204,共3页
中风是危害公共健康的一大疾病,据世界卫生组织统计,2002年有大约550万人死于中风,2002年中风是美国第三大致死原因,仅次于心脏病和癌症,每53秒就有1人发生中风,每3.1分钟就有一人死于中风。除死亡之外,中风带来的最大负担是长... 中风是危害公共健康的一大疾病,据世界卫生组织统计,2002年有大约550万人死于中风,2002年中风是美国第三大致死原因,仅次于心脏病和癌症,每53秒就有1人发生中风,每3.1分钟就有一人死于中风。除死亡之外,中风带来的最大负担是长期而严重的身体和精神残疾。尽管进行了大量的研究探索,中风发生后有效的治疗仍十分有限,因此寻找诱发中风的危险因素,有效地预防中风的发生是目前的首要任务。 展开更多
关键词 中风 高血压 药物治疗 血管紧缩素Ⅱ-受体拮抗剂
原文传递
疫苗治疗高血压
19
作者 王萌 《健康必读(健康新语)》 2015年第8期84-84,共1页
日本大阪大学的研究团队发现了可导致血压升高的物质,即“血管紧缩素”,新研究的治疗就是将可形成血管紧缩素2与其他物质合为一体的蛋白质基因作为疫苗注入体内,之后免疫细胞可识别这种蛋白质,进而产生可减弱血管紧缩素2功能的抗体... 日本大阪大学的研究团队发现了可导致血压升高的物质,即“血管紧缩素”,新研究的治疗就是将可形成血管紧缩素2与其他物质合为一体的蛋白质基因作为疫苗注入体内,之后免疫细胞可识别这种蛋白质,进而产生可减弱血管紧缩素2功能的抗体。就是说,疫苗所生成的血管紧缩素2抗体起到了避免血压上升的作用。 展开更多
关键词 疫苗治疗 高血压 血管紧缩素 日本大阪大学 血压升高 研究团队 免疫细胞 蛋白质
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部